202 related articles for article (PubMed ID: 38255993)
21. Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile.
Peng M
Front Immunol; 2022; 13():970885. PubMed ID: 36003383
[TBL] [Abstract][Full Text] [Related]
22. An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma.
Bai J; Tang R; Zhou K; Chang J; Wang H; Zhang Q; Shi J; Sun C
BMC Med Genomics; 2022 Oct; 15(1):222. PubMed ID: 36284275
[TBL] [Abstract][Full Text] [Related]
23. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
[TBL] [Abstract][Full Text] [Related]
24. Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis.
Sun R; Zhang Z; Bao R; Guo X; Gu Y; Yang W; Wei J; Chen X; Tong L; Meng J; Zhong C; Zhang C; Zhang J; Sun Y; Ling C; Tong X; Yu FX; Yu H; Qu W; Zhao B; Guo W; Qian M; Saiyin H; Liu Y; Liu RH; Xie C; Liu W; Xiong Y; Guan KL; Shi Y; Wang P; Ye D
J Hepatol; 2022 Aug; 77(2):453-466. PubMed ID: 35292350
[TBL] [Abstract][Full Text] [Related]
25. Identification of Proteome-Based Immune Subtypes of Early Hepatocellular Carcinoma and Analysis of Potential Metabolic Drivers.
Diao L; He M; Xu B; Chen L; Wang Z; Yang Y; Xia S; Hu S; Guo S; Li D
Mol Cell Proteomics; 2024 Jan; 23(1):100686. PubMed ID: 38008179
[TBL] [Abstract][Full Text] [Related]
26. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
Front Immunol; 2022; 13():994019. PubMed ID: 36177006
[TBL] [Abstract][Full Text] [Related]
27. Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma.
Yu X; Chen P; Yi W; Ruan W; Xiong X
Front Immunol; 2022; 13():1029872. PubMed ID: 36275676
[TBL] [Abstract][Full Text] [Related]
28. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
[TBL] [Abstract][Full Text] [Related]
29. An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.
Wang J; Lou J; Fu L; Jin Q
J Int Med Res; 2021 Feb; 49(2):300060520980646. PubMed ID: 33567957
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
Xiao Y; Li J; Wu J
BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
[TBL] [Abstract][Full Text] [Related]
31. Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma.
Wang Z; Chen X; Zhang J; Chen X; Peng J; Huang W
Front Immunol; 2023; 14():1204338. PubMed ID: 37680641
[TBL] [Abstract][Full Text] [Related]
32. A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.
Liu C; Wu Z; Wang L; Yang Q; Huang J; Huang J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292980
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma.
Guan Q; Pan J; Ren N; Qiao C; Wei M; Li Z
Front Cell Dev Biol; 2022; 10():960277. PubMed ID: 36147735
[No Abstract] [Full Text] [Related]
34. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
36. Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing.
Chen W; Zhang F; Xu H; Hou X; Tang D; Dai Y
Pathol Oncol Res; 2022; 28():1610199. PubMed ID: 36091935
[TBL] [Abstract][Full Text] [Related]
37. A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment.
Zeng C; Zhang L; Luo C; Yang C; Huang X; Fan L; Li J; Chen F; Luo Z
BMC Cancer; 2022 Jun; 22(1):613. PubMed ID: 35659630
[TBL] [Abstract][Full Text] [Related]
38. Identification of a bile acid and bile salt metabolism-related lncRNA signature for predicting prognosis and treatment response in hepatocellular carcinoma.
Cui H; Lian J; Xu B; Yu Z; Xiang H; Shi J; Gao Y; Han T
Sci Rep; 2023 Nov; 13(1):19512. PubMed ID: 37945918
[TBL] [Abstract][Full Text] [Related]
39. Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis.
Zhang Y; Qin N; Wang X; Liang R; Liu Q; Geng R; Jiang T; Liu Y; Li J
Oncol Res; 2024; 32(3):563-576. PubMed ID: 38361757
[TBL] [Abstract][Full Text] [Related]
40. Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs.
He M; Gu W; Gao Y; Liu Y; Liu J; Li Z
Front Immunol; 2022; 13():1043827. PubMed ID: 36479122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
